Access cutting-edge neurofibromatosis type 1 treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access neurofibromatosis type 1 specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neurofibromatosis type 1 treatment provided free
The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with progressive and/or symptomatic PN.
Sponsor: Healx Limited
Check if you qualify for this neurofibromatosis type 1 clinical trial in Chicago, IL
If you're searching for neurofibromatosis type 1 treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neurofibromatosis type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.